BMRA vs NEM · rev $4.5M vs P/E 14, rev $13.43B
Biomerica Inc (BMRA) versus Newmont Goldcorp Corp (NEM) — a side-by-side from cached financials, not a winner call.
Biomerica Inc (BMRA) is a medical devices company listed on US.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Latest reported BMRA revenue for 2026-05-31 was $4.5M. Net income was -$3.8M. Revenue was down 16.2% from 2025-05-31 to 2026-05-31. BMRA currently screens at market cap $8.0M.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
BMRA currently screens at market cap $8.0M. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Not investment advice. Open the BMRA and NEM stock pages for the full models.
Not investment advice.